Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite

Journal of Biomedical Materials Research - Part A

Volumn 68, Issue 2, 2004, Pages 273-285

  Kilpadi, Krista L ^a,b   Sawyer, Amber A ^a   Prince, Charles W ^a,b   Chang, Pi Ling ^b   Bellis, Susan L ^a,c  

^a and Radiation Oncology   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Fibronectin; Hydroxylapatite; Integrins; Osteoblasts; Vitronectin

Indexed keywords

ADHESION; ANTIBODIES; BONE; COATINGS; PROTEINS; STRESSES; TISSUE CULTURE;

FIBRONECTIN (FN); HUMAN MARROW STROMAL CELLS; INTEGRIN SUBUNITS; OSTEOSARCOMA CELLS; VICTRONECTIN (VN);

BIOMEDICAL ENGINEERING;

ALPHA5 INTEGRIN; ANTIBODY; ARGINYLGLYCYLASPARTIC ACID; CD51 ANTIGEN; FIBRONECTIN; FIBRONECTIN RECEPTOR; HYDROXYAPATITE; INTEGRIN; LIGAND; PROTEIN SUBUNIT; VITRONECTIN; VITRONECTIN RECEPTOR;

ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL STRUCTURE; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; FIBER; HUMAN; HUMAN CELL; MATERIAL COATING; OSTEOSARCOMA CELL; SERUM; STROMA CELL; STRUCTURE ANALYSIS;

EID: 1942452936     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20043     Document Type: Article

References (65)

1. Degasne I, Baslé MF, Demais V, Huré G, Lesourd M, Grolleau B, Mercier L, Chappard D. Effects of roughness, fibronectin, and vitronectin on attachment, spreading, and proliferation of human osteoblast-like cells (SAOS-2) on titanium surfaces. Calcif Tissue Int 1999;64:499-507.
2. Mayr-Wohlfart U, Fiedler J, Günther K-P, Puhl W, Kessler S. Proliferation and differentiation rates of a human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials. J Biomed Mater Res 2001;57:132-139.
3. Sofia S, McCarthy MB, Gronowicz G, Kaplan DL. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 2001;54:139-148.
4. Purves LR, Brown G, Linton N. Fibronectin levels in normal subjects and patients admitted to a respiratory intensive care unit. South African Med J 1982;61:733-736.
5. Gervais A, Schuller E. Fibronectin in plasma and CSF: evidence for its intrathecal synthesis. J Neurol Sci 1991;105:200-205.
6. Kobayashi J, Yamada S, Kawasaki H. Distribution of vitronectin in plasma and liver tissue: relationship to chronic liver disease. Hepatology 1994;20:1412-1417.
7. Boyd NAM, Bradwell AR, Thompson RA. Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice. J Clin Pathol 1993;46:1042-1045.
8. Kilpadi KL, Chang P-L, Bellis SL. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001;57:258-267.
9. Bagambisa FB, Kappert HF, Schilli W. Cellular and molecular biological events at the implant interface. J Craniomaxillofac Surg 1994;22:12-17.
10. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
11. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res 2000;51:475-483.
12. Thomas CH, McFarland CD, Jenkins ML, Rezania A, Steele JG, Healy KE. The role of vitronectin in the attachment and spatial distribution of bone-derived cells on materials with patterned surface chemistry. J Biomed Mater Res 1997;37:81-93.
13. McFarland CD, Mayer S, Scotchford C, Dalton BA, Steele JG, Downes S. Attachment of cultured human bone cells to novel polymers. J Biomed Mater Res 1999;44:1-11.
14. Steele JG, McFarland C, Dalton BA, Johnson G, Evans MDM, Howlett CR, Underwood PA. Attachment of human bone cells to tissue culture polystyrene and to unmodified polystyrene: the effect of surface chemistry upon initial cell attachment. J Biomater Sci Polym Ed 1993;5:245-257.
15. Underwood PA, Bennett FA. A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J Cell Sci 1989;93:641-649.
16. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 1987;262:17294-17298.
17. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog 1999;15:19-32.
18. Ferris DM, Moodie GD, Dimond PM, Gioranni CWD, Ehrlich MG, Valentini RF. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 1999;20:2323-2331.
19. Eid K, Chen E, Griffith L, Glowacki J. Effect of RGD coating on osteocompatibility of PLGA-polymer disks in a rat tibial wound. J Biomed Mater Res 2001;57:224-231.
20. Fujisawa R, Mizuno M, Nodasaka Y, Kuboki Y. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol 1997;16:21-28.
21. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J Biomed Mater Res 1997;37:9-19.
22. Schaffner P, Meyer J, Dard M, Wenz R, Nies B, Verrier S, Kessler H, Kantlehner M. Induced tissue integration of bone implants by coating with bone selective RGD-peptides in vitro and in vivo studies. J Mater Sci Mater Med 1999;10:837-839.
23. Zreiqat H, Ahu Akin F, Howlett CR, Markovic B, Haynes D, Lateef S, Hanley L. Differentiation of human bone-derived cells grown on GRGDSP-peptide bound titanium surfaces. J Biomed Mater Res 2003;64:105-113.
24. Dee KC, Andersen TT, Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J Biomed Mater Res 1998;40:371-377.
25. Dee KC, Andersen TT, Bizios R. Osteoblast population migration characteristics on substrates modified with immobilized adhesive peptides. Biomaterials 1999;20:221-227.
26. Healy KE, Rezania A, Stile RA. Designing biomaterials to direct biological responses. Ann NY Acad Sci 1999;875:24-35.
27. Ebrahimpour A, Johnsson M, Richardson CF, Nancollas GH. The characterization of hydroxyapatite preparations. J Colloid Interf Sci 1993;159:158-163.
28. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999;181:67-73.
29. Chang Y-L, Stanford CM, Wefel JS, Keller JC. Osteoblastic cell attachment to hydroxyapatite-coated implant surfaces in vitro. Int J Oral Maxillofac Implants 1999;14:239-247.
30. Gronthos S, Stewart K, Graves SE, Hay S, Simmons PJ. Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 1997;12:1189-1197.
31. Puleo DA, Bizios R. Mechanisms of fibronectin-mediated attachment of osteoblasts to substrates in vitro. Bone Miner 1992;18:215-226.
32. Zar JH. Biostatistical analysis, 2nd ed. Englewood Cliffs, NJ: Prentice Hall; 1984.
33. Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 1998;50:197-263.
34. Hynes RO. Cell adhesion: old and new questions. Trends Cell Biol 1999;9:M33-M37.
35. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
36. Weinlaender M. Bone growth around dental implants. Dent Clin North Am 1991;35:585-601.
37. Davies JE. In vitro modeling of the bone/implant interface. Anat Rec 1996;245:426-445.
38. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann K, Rodan GA. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 1987;47:4961-4966.
39. Billiau A, Cassiman JJ, Willems D, Verhelst M, Heremans H. In vitro cultivation of human tumor tissues. Oncology 1975;31:257-272.
40. Verrier S, Pallu S, Bareille R, Jonczyk A, Meyer J, Dard M, Amédée J. Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process. Biomaterials 2002;23:585-596.
41. Gronthos S, Simmons PJ, Graves SE, Robey PG. Integrin-mediated interactions between human bone marrow stromal cells and the extracellular matrix. Bone 2001;28:174-181.
42. Lévesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 1995;181:1805-1815.
43. Kinashi T, Asaoka T, Setoguchi R, Takatsu K. Affinity modulation of a very late antigen-5 through phosphatidylinositol 3-kinase in mast cells. J Immunol 1999;162:2850-2857.
44. Dastych J, Metcalfe DD. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 1994;152:213-219.
45. Moursi AM, Globus RK, Damsky CH. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 1997;110:2187-2196.
46. Schneider GB, Zaharias R, Stanford C. Osteoblast integrin adhesion and signaling regulate mineralization. J Dent Res 2001;80:1540-1544.
47. 1 integrins is a required intermediate in interleukin-1β induction of alkaline phosphatase activity in human osteosarcoma cells. Exp Cell Res 1989;183:207-214.
48. Dedhar S. Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin-1β in human osteosarcoma cells: Inhibition of cell proliferation and stimulation of alkaline phosphatase activity. J Cell Physiol 1989;138:291-299.
49. Sudo H, Kodama H-A, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983;96:191-198.
50. Sommerfeldt DW, McLeod KJ, Rubin CT, Hadjiargyrou M. Differential phosphorylation of paxillin in response to surface-bound serum proteins during early osteoblast adhesion. Biochem Biophys Res Commun 2001;285:355-363.
51. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000;2:E231-E236.
52. Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene 2001;20:6459-6472.
53. Ignotz RA, Heino J, Massagué J. Regulation of cell adhesion receptors by transforming growth factor-β: regulation of vitronectin receptor and LFA-1. J Biol Chem 1989;264:389-392.
54. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001;7:4060-4066.
55. Grzesik WJ, Gehron Robey P. Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 1994;9:487-496.
56. Rodan GA. Osteopontin overview. Ann NY Acad Sci 1995;760:1-5.
57. Hayden K, Tetlow L, Byrne G, Bundred N. Radioimmunoassay for the measurement of thrombospondin in plasma and breast cyst fluid: validation and clinical application. Ann Clin Biochem 2000;37:319-325.
58. Clezardin P, Jouishomme H, Chavassieux P, Marie PJ. Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells: a model to study the different effects of thrombospondin in cell adhesion. Eur J Biochem 1989;181:721-726.
59. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng 2001;7:291-301.
60. Steele JG, Johnson G, Underwood PA. Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene. J Biomed Mater Res 1992;26:861-884.
61. Marie PJ. Human endosteal osteoblastic cells: relationship with bone formation. Calcif Tissue Int 1995;56:S13-S16.
62. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000;21:667-681.
63. Garcia AJ, Keselowsky BG. Biomimetic surfaces for control of cell adhesion to facilitate bone formation. Crit Rev Eukaryot Gene Expr 2002;12:151-162.
64. LeBaron RG, Athanasiou KA. Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng 2000;6:85-103.
65. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res (Appl Biomater) 1999;48:913-927.